Guideline for the Diagnosis and Management of Heritable IFNAR1 Deficiency in Oceania
Journal of Paediatrics and Child Health · 2026-07 · 62 (7) · 1113-1120
DOI: 10.1111/jpc.70421 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Paediatrics and Child Health, online erschienen am 11.05.2026. Verfasst von Cecilia Verryt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology & Allergy, Starship Children's Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Receptor, Interferon alpha-beta, Virus Diseases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autosomal recessive interferon alpha and beta receptor subunit 1 (IFNAR1) deficiency is a rare and heritable inborn error of immunity (IEI) predisposing individuals to severe and life‐threatening viral infections. It is more common in people of Western Polynesian ancestry, with estimates of around one in six thousand live births affected, due to being homozygous for or having two copies of the regionally relevant pathogenic IFNAR1 variant c.1156G>T, p.Glu386*. IFNAR1 deficiency confers an increased risk of severe and life‐threatening infections caused by naturally circulating viruses including influenza, SARS‐CoV‐2, herpes simplex virus, respiratory syncytial virus (RSV), arboviruses and viruses in live attenuated vaccines (LAVs) including measles‐mumps‐rubella (MMR) and yellow fever. Complications including virus induced systemic hyperinflammation (VISH) are associated with significant mortality. This document outlines expert consensus regarding early identification, diagnostic workup and management of IFNAR1 deficiency in Australia, Aotearoa New Zealand and Western Pacific nations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology & Allergy, Starship Children's Hospital, Auckland, New Zealand.
- Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
- Department of Paediatrics, Tauranga Hospital, Tauranga, New Zealand.
- Sydney Children's Hospital, Randwick, New South Wales, Australia.
- University of Western Sydney, Sydney, Australia.
- Queensland Paediatric Immunology and Allergy Service, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
ORCID-Profile: Cecilia Verryt, Kuang-Chih Hsiao
Zitieren
APA
Verryt, C., Gray, P., McNaughton, P., Peake, J., Wong, M., Aho, G., Best, E., Brewerton, M., Lutui, F., Tulifau, L. E., Qin, R., Viali, S., White, P., Wood, A., Woon, S. T., Cole, T., Charry, A. P., & Hsiao, K. C. (2026). Guideline for the Diagnosis and Management of Heritable IFNAR1 Deficiency in Oceania. Journal of Paediatrics and Child Health, 62(7), 1113-1120. https://doi.org/10.1111/jpc.70421
Vancouver
Verryt C, Gray P, McNaughton P, Peake J, Wong M, Aho G, et al. Guideline for the Diagnosis and Management of Heritable IFNAR1 Deficiency in Oceania. Journal of Paediatrics and Child Health. 2026;62(7):1113-1120. doi:10.1111/jpc.70421
BibTeX
@article{Verryt2026,
author = {Verryt, Cecilia and Gray, Paul and McNaughton, Peter and Peake, Jane and Wong, Melanie and Aho, George and Best, Emma and Brewerton, Maia and Lutui, Flora and Tulifau, Litara Esera and Qin, Rebecca and Viali, Satupa'itea and White, Petine and Wood, Andrew and Woon, See-Tarn and Cole, Theresa and Charry, Alberto Pinzon and Hsiao, Kuang-Chih},
title = {Guideline for the Diagnosis and Management of Heritable IFNAR1 Deficiency in Oceania},
journal = {Journal of Paediatrics and Child Health},
year = {2026},
volume = {62},
number = {7},
pages = {1113--1120},
doi = {10.1111/jpc.70421}
}
EUVIMED